886 followers
Really enjoyed this detailed, mechanistic overview of bone mets in NSCLC in @FrontOncology! Many clinical questions: role of RANKL and osteoclast inhibitors, esp in #TKI sensitive cancers? VEGF synergy? Adiponectin as therapeutic target? Much more! @oncoa